Cart
0

Cytogenetics Market by Product (Consumables, Instruments, and Software & Services), Technique (Comparative Genomic Hybridization, Fluorescence in Situ Hybridization (FISH), Karyotyping, Immunohistochemistry, and Others), Application (Genetic Disorders, Cancer, Personalized Medicine, and Others), and End User (Clinical & Research Laboratories, Pharmaceutical & Biotechnology Companies, Academic Research Institutes, and Others) - Global Opportunity Analysis and Industry Forecast, 2018-2025

Get 20% Free Customization In This Report
LI_182116
Pages: 185
Jul 2018 | 2384 Views
 
Author's : Pallavi Jaiswal & Sohail Shaikh
Tables: 132
Charts: NA
 

Cytogenetics Market Overview:

The global cytogenetics market was valued at $1,121 million in 2017, and is projected to reach $3,097 million by 2025 at a CAGR of 13.5% from 2018 to 2025. Cytogenetics is the study of chromosomes present in cell and tissues. This study is further applied in the field of biology and medicine to better understand genetic disorders such as cancer, sickle cell anemia, cystic fibrosis, Down’s syndrome, and others. Moreover, cytogenetics is used in the development of personal medicine, targeted cancer treatment, and others. Currently, a wide range of techniques such as comparative genomic hybridization, fluorescence in situ hybridization, karyotyping, and others are employed for the screening of genetic abnormalities and cancers. These techniques employ the use of cytogenetic products such as kits, media, reagents, and others.

Get more information on this report : Request Sample Pages

Market Dynamics

The growth of the global cytogenetics market is majorly driven by increase in incidence of genetic disorders and cancer. Other factors boosting the market growth include increase in focus on targeted cancer treatment, rise in aging population, and increase in prevalence of chronic diseases. However, high cost of cytogenetic instruments hampers the market growth. Conversely, transition from fluorescence in situ hybridization to array based is expected to provide lucrative growth opportunities for the global market.

Market Segmentation

The global cytogenetics market is segmented into product, technique, application, end user, and region. On the basis of product, the market is bifurcated into consumables, instruments, and software & services. The consumables segment accounted for the largest market share in 2017, and is expected to remain dominant throughout the forecast period, owing to their niche use in developed and developing economies. Furthermore, new launches such as Sysmex Corporation’s subsidiary, Oxford Gene Technology launched Cytocell Aquarius, a cost-effective fluorescence in situ hybridization (FISH) kit for the reliable investigation of glial tumors.

Get more information on this report : Request Sample Pages

By technique, the cytogenetics market is categorized into comparative genomic hybridization, fluorescence in situ hybridization, karyotyping, immunohistochemistry, and other techniques. The comparative genomic hybridization segment accounted for the largest market share in 2017, owing to ease in analysis of thousands of sequences with an extremely high resolution along with detection of single nucleotide polymorphism (SNP).

Get more information on this report : Request Sample Pages

Based on region, the cytogenetics market is studied across North America, Europe, Asia-Pacific, and LAMEA. North America held the largest share of the market in 2017, followed by Europe. On the other hand, the Asia-Pacific region is anticipated to dominate the market during the forecast period, owing to increase in disposable income and enhanced patient awareness about genetic disorder and cancer. Moreover, Asia is a large continent, and has emerged as an epicenter of a large percentage of population.

Get more information on this report : Request Sample Pages

The key players of this market include Abbott Laboratories, Agilent Technologies, Inc., Applied Spectral Imaging, Inc., Empire Genomics, LLC., Illumina, Inc., Irvine Scientific., OPKO Health, Inc. (GeneDx.), PerkinElmer Inc., Sysmex Corporation (Oxford Gene Technology), and Thermo Fisher Scientific, Inc.

Other players (these players are not profiled in the report and the same can be included on request) in the value chain include Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., and MetaSystems.

Key Benefits for Stakeholders

  • The study provides an in-depth analysis of the global cytogenetics industry with current trends and future estimations from 2017 to 2025 to elucidate the imminent investment pockets.
  • A comprehensive analysis of factors that drive and restrict the market growth is provided.
  • Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on global and regional scales are provided.
  • The profiles of the key players and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

Cytogenetics Market Key Segments:

By Product

  • Consumables
  • Testing Kits, Media, and Reagents
  • Probes
  • Others(Affinity Reagents and Stains)
  • Instruments
  • Software & Services

By Techniques

  • Comparative Genomic Hybridization  
  • Fluorescence in Situ Hybridization  
  • Karyotyping
  • Immunohistochemistry
  • Others

By Application

  • Genetic Disorders
  • Cancer
  • Personalized Medicine
  • Others

By End User

  • Clinical & Research Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institutes
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

Chapter 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/ TOP PLAYER POSITIONING, 2017
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter 4 CYTOGENETICS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. Consumable

4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by product type

4.2.2.1. Testing kits, media, and reagents

4.2.2.1.1. Market size and forecast

4.2.2.2. Probes

4.2.2.2.1. Market size and forecast

4.2.2.3. Others(affinity reagents and stains)

4.2.2.3.1. Market size and forecast

4.2.3. Market size and forecast, by region
4.2.4. Market analysis, by country

4.3. Instrument

4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

4.4. Software & service

4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country

Chapter 5 CYTOGENETICS MARKET, BY TECHNIQUE

5.1. Overview

5.1.1. Market size and forecast

5.2. Comparitive genome hybridization

5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country

5.3. Fluorescence in situ hybridization

5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country

5.4. Karyotyping

5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country

5.5. Immunohistochemistry

5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country

5.6. Others

5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by country

Chapter 6 CYTOGENETICS MARKET, BY APPLICATION

6.1. Overview

6.1.1. Market size and forecast

6.2. Genetic disorder

6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country

6.3. Cancer

6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country

6.4. Personalized medicine

6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country

6.5. Other

6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by country

Chapter 7 CYTOGENETICS MARKET, BY END USER

7.1. Overview

7.1.1. Market size and forecast

7.2. Clinical and research laboratory

7.2.1. Market size and forecast, by region
7.2.2. Market analysis, by country

7.3. Pharmaceutical and biotechnology company

7.3.1. Market size and forecast, by region
7.3.2. Market analysis, by country

7.4. Academic Research Institute

7.4.1. Market size and forecast, by region
7.4.2. Market analysis, by country

7.5. Other

7.5.1. Market size and forecast, by region
7.5.2. Market analysis, by country

Chapter 8 CYTOGENETICS MARKET, BY REGION

8.1. OVERVIEW
8.2. NORTH AMERICA

8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast

8.2.2.1. U.S. market size and forecast

8.2.2.1.1. U.S. market size and forecast, by product
8.2.2.1.2. U.S. market size and forecast, by technique
8.2.2.1.3. U.S. market size and forecast, by application
8.2.2.1.4. U.S. market size and forecast, by end user

8.2.2.2. Canada market size and forecast

8.2.2.2.1. Canada market size and forecast, by product
8.2.2.2.2. Canada market size and forecast, by technique
8.2.2.2.3. Canada market size and forecast, by application
8.2.2.2.4. Canada market size and forecast, by end user

8.2.2.3. Mexico market size and forecast

8.2.2.3.1. Mexico market size and forecast, by product
8.2.2.3.2. Mexico market size and forecast, by technique
8.2.2.3.3. Mexico market size and forecast, by application
8.2.2.3.4. Mexico market size and forecast, by end user

8.2.3. North America cytogenetics market, by product
8.2.4. North America cytogenetics market, by technique
8.2.5. North America cytogenetics market, by application
8.2.6. North America cytogenetics market, by end user

8.3. EUROPE

8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast

8.3.2.1. Germany market size and forecast

8.3.2.1.1. Germany market size and forecast, by product
8.3.2.1.2. Germany market size and forecast, by technique
8.3.2.1.3. Germany market size and forecast, by application
8.3.2.1.4. Germany market size and forecast, by end user

8.3.2.2. France market size and forecast

8.3.2.2.1. France market size and forecast, by product
8.3.2.2.2. France market size and forecast, by technique
8.3.2.2.3. France market size and forecast, by application
8.3.2.2.4. France market size and forecast, by end user

8.3.2.3. UK market size and forecast

8.3.2.3.1. UK market size and forecast, by product
8.3.2.3.2. UK market size and forecast, by technique
8.3.2.3.3. UK market size and forecast, by application
8.3.2.3.4. UK market size and forecast, by end user

8.3.2.4. Italy market size and forecast

8.3.2.4.1. Italy market size and forecast, by product
8.3.2.4.2. Italy market size and forecast, by technique
8.3.2.4.3. Italy market size and forecast, by application
8.3.2.4.4. Italy market size and forecast, by end user

8.3.2.5. Spain market size and forecast

8.3.2.5.1. Spain market size and forecast, by product
8.3.2.5.2. Spain market size and forecast, by technique
8.3.2.5.3. Spain market size and forecast, by application
8.3.2.5.4. Spain market size and forecast, by end user

8.3.2.6. Rest of Europe market size and forecast

8.3.2.6.1. Rest of Europe market size and forecast, by product
8.3.2.6.2. Rest of Europe market size and forecast, by technique
8.3.2.6.3. Rest of Europe market size and forecast, by application
8.3.2.6.4. Rest of Europe market size and forecast, by end user

8.3.3. Europe cytogenetics market, by product
8.3.4. Europe cytogenetics market, by technique
8.3.5. Europe cytogenetics market, by application
8.3.6. Europe cytogenetics market, by end user

8.4. ASIA-PACIFIC

8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast

8.4.2.1. Japan market size and forecast

8.4.2.1.1. Japan market size and forecast, by product
8.4.2.1.2. Japan market size and forecast, by technique
8.4.2.1.3. Japan market size and forecast, by application
8.4.2.1.4. Japan market size and forecast, by end user

8.4.2.2. China market size and forecast

8.4.2.2.1. China market size and forecast, by product
8.4.2.2.2. China market size and forecast, by technique
8.4.2.2.3. China market size and forecast, by application
8.4.2.2.4. China market size and forecast, by end user

8.4.2.3. India market size and forecast

8.4.2.3.1. India market size and forecast, by product
8.4.2.3.2. India market size and forecast, by technique
8.4.2.3.3. India market size and forecast, by application
8.4.2.3.4. India market size and forecast, by end user

8.4.2.4. Australia market size and forecast

8.4.2.4.1. Australia market size and forecast, by product
8.4.2.4.2. Australia market size and forecast, by technique
8.4.2.4.3. Australia market size and forecast, by application
8.4.2.4.4. Australia market size and forecast, by end user

8.4.2.5. South Korea market size and forecast

8.4.2.5.1. South Korea market size and forecast, by product
8.4.2.5.2. South Korea market size and forecast, by technique
8.4.2.5.3. South Korea market size and forecast, by application
8.4.2.5.4. South Korea market size and forecast, by end user

8.4.2.6. Rest of Asia-Pacific market size and forecast

8.4.2.6.1. Rest of Asia-Pacific market size and forecast, by product
8.4.2.6.2. Rest of Asia-Pacific market size and forecast, by technique
8.4.2.6.3. Rest of Asia-Pacific market size and forecast, by application
8.4.2.6.4. Rest of Asia-Pacific market size and forecast, by end user

8.4.3. Asia-Pacific cytogenetics market, by product
8.4.4. Asia-Pacific cytogenetics market, by technique
8.4.5. Asia-Pacific cytogenetics market, by application
8.4.6. Asia-Pacific cytogenetics market, by end user

8.5. LAMEA

8.5.1. Key market trends, growth factors and opportunities
8.5.2. Market size and forecast

8.5.2.1. Brazil market size and forecast

8.5.2.1.1. Brazil market size and forecast, by product
8.5.2.1.2. Brazil market size and forecast, by technique
8.5.2.1.3. Brazil market size and forecast, by application
8.5.2.1.4. Brazil market size and forecast, by end user

8.5.2.2. Saudi Arabia market size and forecast

8.5.2.2.1. Saudi Arabia market size and forecast, by product
8.5.2.2.2. Saudi Arabia market size and forecast, by technique
8.5.2.2.3. Saudi Arabia market size and forecast, by application
8.5.2.2.4. Saudi Arabia market size and forecast, by end user

8.5.2.3. South Africa market size and forecast

8.5.2.3.1. South Africa market size and forecast, by product
8.5.2.3.2. South Africa market size and forecast, by technique
8.5.2.3.3. South Africa market size and forecast, by application
8.5.2.3.4. South Africa market size and forecast, by end user

8.5.2.4. Rest of LAMEA market size and forecast

8.5.2.4.1. Rest of LAMEA market size and forecast, by product
8.5.2.4.2. Rest of LAMEA market size and forecast, by technique
8.5.2.4.3. Rest of LAMEA market size and forecast, by application
8.5.2.4.4. Rest of LAMEA market size and forecast, by end user

8.5.3. LAMEA cytogenetics market, by product
8.5.4. LAMEA cytogenetics market, by technique
8.5.5. LAMEA cytogenetics market, by application
8.5.6. LAMEA cytogenetics market, by end user

Chapter 9 COMPANY PROFILES

9.1. Abbott Laboratories

9.1.1. Operating business segments
9.1.2. Business performance
9.1.3. Key strategic moves and developments

9.2. Agilent Technologies, Inc.

9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments

9.3. Applied Spectrial Imaging, Inc.

9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments

9.4. Empire Genomics, LLC

9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments

9.5. Illumina, Inc.

9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments

9.6. Irvine Scientific

9.6.1. Operating business segments
9.6.2. Business performance
9.6.3. Key strategic moves and developments

9.7. OPKO Health, Inc.

9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments

9.8. PerkinElmer, Inc.

9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments

9.9. Sysmex Corporation

9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments

9.10. Thermo Fisher Scientific, Inc.

9.10.1. Operating business segments
9.10.2. Business performance
9.10.3. Key strategic moves and developments

 

Cytogenetics is a diverse field of genetics extensively employed for the study of chromosomes. The study of chromosomes help in the detection of genetic disorders arising due to chromosomal abnormalities. Thus, cytogenetics is applied for screening of genetic disorders such as cancer, cystic fibrosis, sickle cell anemia, and others. The growth of cytogenetics market is propelled by rise in incidence of cancer and genetic disorders. Furthermore, increase in awareness & acceptance of personalized medicines, growth in penetration of molecular cytogenetics in clinical pathological testing, and rise in focus on targeted cancer treatment are the key factors anticipated to boost the market growth in the near future.

The use of cytogenetics is highest in North America, owing to efforts taken by government and pharmaceutical companies towards the spread of awareness related to genetic disorders, followed by Europe and Asia-Pacific. Moreover, rise in prevalence of genetic disorders and presence of most of the major key players in this region contribute towards the growth of the market. In addition, instrument manufacturing companies have focused on expanding their presence in the emerging economies, which is anticipated to drive the market growth.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Cytogenetics Market- Global Opportunity Analysis and Industry Forecast, 2018-2025

  • Online Only
  • $3456
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo